Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

NCT04304820 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

NIH

Sponsor class

Conditions

Severe Aplastic Anemia

Interventions

DRUG: Eltrombopag
DRUG: Cyclosporine
DRUG: Horse-Anti-thymocyte-Globulin

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)